Share Twitter LinkedIn Facebook Email Joan Schiller, MD, shares the validity of Tumor Mutation Burden (TMB) as a biomarker at Annual Meeting 2018.
Sumanta (Monty) Kumar Pal, MD – Highlights and Insights from MOASC 2024 Summit: Pioneering Oncology Research and Celebrating Young Investigators General 3 Mins Read